Abstract
Field of the Disclosure:
The present disclosure relates to acid addition salts of N-[5-[[4-[4-[(dimethylamino) methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl] acrylamide of formula-1 referred to as Lazertinib which is represented by the following structural formula.
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
MSN Laboratories Private Limited, R&D Center, Hyderabad, India, Srinivasan Thirumalai Rajan, Sagyam Rajeshwar Reddy, Kommera Rajashekar, Garai Abhijit, Rajavel B, "Acid addition salts of N-[5-[[4-[4-[(dimethylamino)methyl]-3- phenylpyrazol-1-yl] pyrimidin-2-yl]amino]-4-methoxy-2-morpholin -4-ylphenyl]acrylamide and process for the preparation thereof", Technical Disclosure Commons, ()
https://www.tdcommons.org/dpubs_series/11665